Opioid overdose killed more than 80,000 Americans in 2023, according to the CDC, making it the deadliest drug crisis in U.S. history. Medication-assisted treatment for opioids is the evidence-based medical response to that crisis, and understanding how it works is the first step toward getting effective help.
What Medication-Assisted Treatment for Opioids Actually Is
Medication-assisted treatment, or MAT, combines FDA-approved medication with behavioral counseling to treat opioid use disorder as the medical condition it is. The simplest version of this: a doctor prescribes medication that stabilizes your brain chemistry, and you work alongside a counselor to address the patterns that surround your use. Together, those two components constitute a complete treatment.
The framing matters here. MAT is not a workaround or a lesser form of recovery. SAMHSA recognizes it as the standard of care for opioid use disorder, and the research behind it is decades deep. What this means in practice: if you have opioid use disorder, you deserve the same medical treatment someone with diabetes or high blood pressure receives. Medication is part of that treatment.
The Medications Used in MAT
A 2021 NEJM review of more than 40 clinical trials confirmed that FDA-approved medications for opioid use disorder reduce overdose deaths, improve treatment retention, and lower rates of illicit drug use compared to no medication. Three medications are currently approved: buprenorphine, methadone, and naltrexone. Each works differently, and the right choice depends on your situation.
Buprenorphine (Suboxone)
Buprenorphine is a partial opioid agonist, which in plain English means it activates the same brain receptors as opioids but only partially. The result: cravings and withdrawal symptoms ease, but the euphoric high that drives compulsive use does not occur. It also has a “ceiling effect,” meaning taking more than a therapeutic dose produces no additional effect, which makes it safer than full agonists.
One of the most practical aspects of buprenorphine is that a licensed prescriber can provide it in an outpatient setting. You do not need to check into a residential facility or rearrange your entire life. In Maryland, prescriber-led outpatient care means you can start buprenorphine treatment at a clinic visit and pick up your prescription at a local pharmacy, often on the same day as your intake appointment.
Methadone
Methadone is a full opioid agonist that works by occupying opioid receptors completely, which eliminates withdrawal symptoms and blocks the effects of other opioids. It has been used in MAT since the 1960s and has a long record of effectiveness, particularly for people with severe or long-standing opioid dependence.
The practical reality of methadone: it must be dispensed through a federally licensed opioid treatment program, which typically means daily clinic visits, at least at the start of treatment. As you progress, take-home doses become available. For some people, the structure of daily clinic visits is actually helpful early on. For others, the logistics are a barrier worth discussing with a provider.
Naltrexone (Vivitrol)
Naltrexone works differently from the other two medications. Instead of partially or fully activating opioid receptors, it blocks them entirely. If opioids are taken while naltrexone is active, they have no effect. That makes it an option for people who want a non-opioid treatment path.
The catch is that naltrexone requires complete detoxification first. Any opioids in your system when you start it will trigger severe withdrawal. For people who have completed detox and want a medication that removes the option of getting high entirely, the injectable monthly form known as Vivitrol is a practical choice. One shot per month replaces a daily pill, which removes the daily decision from the equation.
Why MAT Works: What the Research Shows
A 2020 NIDA analysis tracking more than 17,000 patients found that those receiving buprenorphine or methadone were significantly less likely to die of overdose than those receiving no medication, with overdose mortality reduced by more than 50 percent in the treated group. The mechanism is straightforward: MAT keeps people alive and stable long enough for recovery to take hold.
Treatment retention is equally important. People who stay in treatment longer have better outcomes across every measure, and medication dramatically improves retention. If you are considering starting, the most effective action you can take is asking your provider at the first appointment about starting medication that same day rather than waiting. Early stabilization is where the evidence points.
The “Substituting One Addiction for Another” Myth
This is the most common reason people delay or avoid MAT, and it is worth addressing directly. A 2016 Johns Hopkins study examining patients on buprenorphine maintenance found no evidence that therapeutic use of the medication constitutes addiction. Addiction is characterized by compulsive use despite harm, loss of control, and escalating doses in pursuit of a high. None of those apply to someone taking a stable, prescribed dose of buprenorphine or methadone.
What is actually happening in MAT is this: the medication stabilizes the neurochemical dysregulation that opioid dependence creates. There are no cycles of highs and crashes, no compulsive dose-seeking, no impairment. The brain gets what it needs to function normally. That is treatment, not addiction. Anyone who tells you otherwise is repeating a stigma, not a fact.
What MAT Treatment Actually Looks Like Day to Day
A 2019 study published in JAMA Psychiatry found that patients receiving medication plus behavioral counseling had significantly better outcomes than those receiving medication alone, with higher rates of sustained abstinence and fewer relapses over 12 months. MAT is not just a prescription. It is a coordinated treatment model.
For most people, the first weeks look like this: an intake appointment where a prescriber evaluates your history and recommends a medication, a prescription filled at a pharmacy (often confirmed before you leave the office), and follow-up appointments that include both medication management and counseling. If you want to understand what that first clinic visit looks like in detail, knowing what to expect removes one more reason to put it off.
The Role of Counseling in MAT
Medication addresses the physical side of opioid dependence. Counseling addresses everything else: the triggers, the thought patterns, the circumstances that made opioids feel necessary in the first place. These two components are not interchangeable, and neither is optional in a well-designed MAT program.
Co-occurring conditions like anxiety, depression, and trauma are common among people with opioid use disorder, and they are treatable alongside it. Integrated behavioral health support means those conditions get attention at the same time, not sequentially. In practice, this is what keeps treatment from feeling like a patch on a larger wound.
Who Qualifies for MAT and How to Start in Maryland
Most adults with a diagnosis of opioid use disorder qualify for MAT. The diagnostic threshold is lower than many people expect: you do not need to have hit a particular bottom or been using for a specific length of time. If opioids are creating problems in your life and you want help, that is enough.
Insurance access in Maryland is broader than most people realize. Medicaid covers MAT, and Maryland’s Medicaid program has no prior authorization requirement for buprenorphine, meaning treatment does not get delayed by insurance paperwork. Commercial plans cover it as well, and understanding your options for opioid treatment across Maryland can help you identify what fits your situation financially before you make a call.
MD M.A.T.T. accepts Medicaid, all major insurance plans, and works with patients who have no coverage. Same-day and next-day intake appointments are available across locations in Baltimore, College Park, Linthicum Heights, Nottingham, and Owings Mills. Pharmacy pickup is confirmed before you leave, and if transportation is a barrier, rides can be arranged through your insurance. More than 92 percent of new patients remain in treatment, which reflects what happens when logistics stop being the reason people don’t follow through.
The one step worth taking this week: call a MAT provider in your area and ask about same-day intake. You do not need to have everything figured out before that call. The appointment is where the figuring out begins.